Strategic Accounts Director, OneStudyTeam
Digital tools for clinical trials
Job no longer available
Digital tools for clinical trials
201-500 employees
Job no longer available
201-500 employees
Company mission
To pave the way to faster, predictable, and more accessible clinical trials.
Role
Who you are
- Previous experience selling into Life Sciences / Clinical R&D is required
- Selling software directly to VPs of Clinical Development, VP Clinical Ops, Clinical Trial Leaders, CROs, and CxOs of life sciences companies that conduct clinical research
- Bachelor's degree preferred but not required
- 6+ years experience successfully running the full sales cycle (cold call to close) of a complex SaaS solution
- Proven record of exceeding revenue targets, including routinely achieving 7-figure annual sales goals
- Experience with native SaaS solutions, and their unique value relative to on-premise solutions
- Superb interpersonal and presentation skills (including web presentation)
- Ability to work independently but within a team environment
- Willingness to travel – Frequent/ongoing (35-40%)
What the job involves
- Develop and execute sales strategy within assigned region
- Manage full sales cycle: Develop, advance, and close sales opportunities and software agreements
- Deliver compelling demonstrations that display the product’s value proposition
- Identify prospects, build pipelines, and conduct effective, consultative and discovery meetings with prospects to assess needs and understand their process and existing systems
- Work in close coordination with executive management and other internal teams (Marketing, SDRs, Customer Success)
Our take
Clinical research remains a significant bottleneck on drug development. Much of this is due to the slow and unpredictable nature of patient enrolment. OneStudyTeam is tackling this problem with a platform that helps biopharma companies and research sites to enroll trials in three to four months instead of 18 months.
The company's tools are already being used by top-20 global biopharma companies such as Amgen, AstraZeneca, and Eli Lilly & Company, and across a total of over 5,000 research sites across 65 countries. In 2022, OneStudyTeam invested $220 million into improving diversity in clinical trials. This is a strong indicator of the company’s future-facing outlook and its impressive financial backing.
The business is scaling fast, reaching Unicorn status with its Series C round in 2021 and expanding its reach to 10,000 research sites globally. If this trajectory continues, OneStudyTeam could become one of the leading names in the pharmaceutical and healthcare industries.
Kirsty
Company Specialist at Welcome to the Jungle
Insights
-34% employee growth in 12 months
Company
Funding (last 2 of 5 rounds)
Apr 2022
$220m
SERIES D
Aug 2021
$220m
SERIES C
Total funding: $477.6m
Company benefits
- Comprehensive health and wellness
- Generous parental leave
- Flexible paid time off
- 401(k) company match
Company HQ
Downtown Crossing, Boston, MA
Leadership
Ralph Passarella
(CEO & Co-Founder)Founded Reify Health in 2012 whilst completing a PhD/MD at The Johns Hopkins University School of Medicine. Also Co-Founder and Board Member at Signal Vine.
Share this job